Pfizer and BioNTech’s Covid vaccine is protected and generates ‘robust’ immune response in kids ages 5 to 11
Pfizer and BioNTech’s Covid-19 vaccine is safe and generates a “robust” immune response in a clinical trial of children ages 5 to 11, the drugmakers reported in a press release Monday. The organizations tested a two-dose regimen of 10 micrograms — about a third the dosage utilized for teens and adults — directed three weeks…